Cigna Corporation (CI) Income Statement

The sequential acceleration in revenue growth suggests that Evernorth's service volumes remain robust, likely benefiting from new client wins and specialty drug volume. However, the growth is heavily weighted toward the pass-through PBM business, which inflates the top line without commensurate margin expansion. Investors should monitor whether this growth translates into higher fee-based income or merely reflects drug cost inflation.

The sharp drop in the loss ratio in Q2 2026 is notable, but it may reflect seasonal patterns or reserve adjustments rather than a fundamental improvement in claims experience. The combined ratio has remained consistently below 100%, indicating that Cigna is generating underwriting profits. However, the elevated loss ratio in Q1 2026 (90.6%) suggests that medical cost trends are not entirely predictable, and investors should watch for any sustained upward pressure on claims.

The gap between operating income and net income suggests that non-operating items, including reserve releases, are contributing to bottom-line results. While reserve releases are a legitimate source of earnings, they are not sustainable indefinitely. If medical cost trends deteriorate, the absence of these releases could expose underlying margin pressure. Analysts should assess the adequacy of current reserves by monitoring the days claims payable metric.

The absence of reported investment income suggests that Cigna's earnings are not significantly dependent on investment yields, unlike traditional insurers. This reduces sensitivity to interest rate fluctuations but also means that the company cannot rely on investment gains to offset underwriting losses. The focus remains on operational efficiency and cost management.

The stable expense ratio suggests that Cigna is effectively managing its cost base while scaling its Evernorth services. However, the low expense ratio also reflects the high proportion of pass-through pharmacy costs, which do not require proportional overhead. The company's investment in technology and AI, as highlighted by management, may help sustain this efficiency, but the impact is not yet visible in the financials.